<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV)-encoded small <z:chebi fb="40" ids="33697">RNAs</z:chebi> (EBERs) are nonpolyadenylated, untranslated <z:chebi fb="40" ids="33697">RNAs</z:chebi>, exist most abundantly in latently EBV-infected cells, and are expected to show secondary structures with many short stem-loops </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="2" ids="26536">Retinoic acid</z:chebi>-inducible gene I (RIG-I) is a cytosolic protein that detects <z:mp ids='MP_0001799'>viral</z:mp> double-stranded <z:chebi fb="40" ids="33697">RNA</z:chebi> (dsRNA) inside the cell and initiates signaling pathways leading to the induction of protective cellular genes, including type I interferons (IFNs) </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated whether EBERs were recognized by RIG-I as dsRNA </plain></SENT>
<SENT sid="3" pm="."><plain>Transfection of RIG-I plasmid induced IFNs and IFN-stimulated genes (ISGs) in EBV-positive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells, but not in their EBV-negative counterparts or EBER-knockout EBV-infected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Transfection of EBER plasmid or in vitro-synthesized EBERs induced expression of type I IFNs and ISGs in RIG-I-expressing, EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells, but not in RIG-I-minus counterparts </plain></SENT>
<SENT sid="5" pm="."><plain>EBERs activated RIG-I's substrates, NF-kappaB and IFN regulatory factor 3, which were necessary for type I IFN activation </plain></SENT>
<SENT sid="6" pm="."><plain>It was also shown that EBERs co-precipitated with RIG-I </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that EBERs are recognized by RIG-I and activate signaling to induce type I IFN in EBV-infected cells </plain></SENT>
</text></document>